APA (7th ed.) Citation

LH, B., LA, B., P, C., H, R., KA, W., K, H., . . . L, M. (2024). CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 73(2), 1. https://doi.org/10.15585/mmwr.rr7302a1

Chicago Style (17th ed.) Citation

LH, Bachmann, Barbee LA, Chan P, Reno H, Workowski KA, Hoover K, Mermin J, and Mena L. "CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024." MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports 73, no. 2 (2024): 1. https://doi.org/10.15585/mmwr.rr7302a1.

MLA (9th ed.) Citation

LH, Bachmann, et al. "CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024." MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, vol. 73, no. 2, 2024, p. 1, https://doi.org/10.15585/mmwr.rr7302a1.